• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒感染:苏格兰的死亡率、发病率及医疗服务成本

Hepatitis B virus infection: mortality, morbidity and the cost to the health service in Scotland.

作者信息

Smith W C

出版信息

J Infect. 1983 Nov;7(3):231-5. doi: 10.1016/s0163-4453(83)97115-3.

DOI:10.1016/s0163-4453(83)97115-3
PMID:6663082
Abstract

This study assessed the size and character of hepatitis B virus infection in Scotland in 1980 by looking at laboratory reports, registration of deaths and hospital discharges. Less than half the laboratory reports of hepatitis B virus infection were associated with hepatic disorder and the overall attack rate in Scotland in 1980 was 2.8 per 100 000. The case fatality for active infection was 2.1 per cent. Most clinical cases were admitted to hospital and their mean duration of stay was 12.9 days. The cost of hospital treatment of hepatitis B virus infection in Scotland was considerably less than the equivalent cost in Europe, probably as a result of the lower cost of treatment and a lower attack rate in Scotland.

摘要

本研究通过查阅实验室报告、死亡登记和医院出院记录,评估了1980年苏格兰乙型肝炎病毒感染的规模和特征。不到一半的乙型肝炎病毒感染实验室报告与肝脏疾病相关,1980年苏格兰的总体发病率为每10万人2.8例。活动性感染的病死率为2.1%。大多数临床病例入院治疗,平均住院时间为12.9天。苏格兰乙型肝炎病毒感染的住院治疗费用远低于欧洲的同等费用,这可能是由于治疗成本较低以及苏格兰的发病率较低。

相似文献

1
Hepatitis B virus infection: mortality, morbidity and the cost to the health service in Scotland.乙型肝炎病毒感染:苏格兰的死亡率、发病率及医疗服务成本
J Infect. 1983 Nov;7(3):231-5. doi: 10.1016/s0163-4453(83)97115-3.
2
Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.爱尔兰乙肝疫苗接种策略的成本效益:一项经济评估。
Eur J Public Health. 2008 Jun;18(3):275-82. doi: 10.1093/eurpub/ckm123. Epub 2007 Dec 26.
3
Costs of viral hepatitis B in the Republic of Korea, 2002-2015.韩国 2002-2015 年乙型肝炎病毒相关成本。
J Viral Hepat. 2020 Feb;27(2):156-167. doi: 10.1111/jvh.13219. Epub 2019 Nov 14.
4
[Characteristics of patients and their medical cost on 14,398 hospitalized patients suffered form hepatitis B, from a hospital of infectious diseases located in Beijing].
Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Apr;32(4):392-5.
5
Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.英国婴幼儿乙型肝炎疫苗接种的经济学评价。
Vaccine. 2011 Jan 10;29(3):466-75. doi: 10.1016/j.vaccine.2010.10.075. Epub 2010 Nov 10.
6
Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal.马尼帕尔医院收治患者中乙肝表面抗原和抗体的流行情况。
Indian J Public Health. 1994 Jul-Sep;38(3):108-12.
7
Hepatitis B surveillance in Singapore.新加坡的乙肝监测
Ann Acad Med Singap. 1980 Apr;9(2):136-41.
8
Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.乙肝疫苗:对其预防乙肝病毒感染应用的药物经济学评估
Pharmacoeconomics. 1994 Feb;5(2):141-71. doi: 10.2165/00019053-199405020-00008.
9
The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.在莫桑比克将乙型肝炎疫苗引入婴儿免疫服务的成本效益。
Health Policy Plan. 2005 Jan;20(1):50-9. doi: 10.1093/heapol/czi006.
10
Surveillance of hepatitis B virus infection in Scotland, 1973-1982.1973 - 1982年苏格兰乙型肝炎病毒感染监测
J Hyg (Lond). 1984 Oct;93(2):233-6. doi: 10.1017/s0022172400064755.